The sale of goods or equipment used to regulate and maintain a particular body temperature for a predetermined time through external warming or cooling constitutes the temperature management market. Temperature management devices are used in operating rooms, ICUs, blood warming, and other chronic conditions like cancer, cardiac, and neurological disorders.
The burden of cardiovascular and cancer diseases is increasing rapidly over time. The demand for efficient treatments for these illnesses, like thermal therapies and operations, is rising. The demand for these devices will increase due to the need to maintain the human body temperature for these treatment options. As an illustration, according to the National Cancer Institute, hyperthermia, also known as thermal therapy or thermotherapy, is a type of therapy in which body tissue is heated to as high as 113 °F to help damage and kill cancer cells with little to no harm to normal tissue. Patients must maintain their body temperature to receive hyperthermia treatments, which will hasten market expansion.
The demand for patient temperature management devices has grown over the past few years due to the prevalence of cancer and cardiovascular diseases, as well as an increase in surgical procedures. These and other factors, as well as technological development, research, and development studies that eliminate the risks related to using these devices, and the introduction of reasonably priced temperature management devices, will all contribute to market growth in the future. The high rate of targeted temperature management (TTM) modality adoption for enhancing neurological outcomes in patients with out-of-hospital cardiac arrest will also support future market growth. According to a study published in July 2019 titled "Door to Targeted Temperature Management Initiation Time and Outcomes in Out-of-Hospital Cardiac Arrest: Insights from the Continuous Chest Compressions Trial," initiating TTM within 122 minutes of hospital admission was associated with improved survival. Patients who use TTM see better results because it is more effective, which will spur market growth.
North America is the most significant revenue contributor and is anticipated to grow at a CAGR of 3.6% during the forecast period. Americans dominate the market for temperature controls. The market under study is growing due to technological improvements, increased traumatic brain injuries, cardiovascular diseases like cardiac arrests, and significant market players in the country. A further factor that may encourage increased use of these devices is the frequency of temperature management product launches in the U.S., which is anticipated to fuel the market's growth there.
Europe is anticipated to grow at a CAGR of 4.03% over the forecast period. Germany has a sizable base of international medical device companies working on developing new products due to the high prevalence of cardiovascular diseases. Additionally, the majority of the expansion in the German temperature control market is due to cardiovascular surgeries. Further, it is anticipated that the expansion of the under-researched German market will be fueled by growing advancements in product development through R&D. For instance, according to a study by German researchers published in Intensive Care Medicine and Anesthesiology in May 2021 and titled "Measuring Core Body Temperature Using a Non-invasive, Disposable Double-Sensor During Targeted Temperature Management in Post-cardiac Arrest Patients," measuring core body temperature with a non-invasive, disposable sensor showed excellent reliability during targeted temperature management in patients who had survived cardiac arrest. This will lead to the development of sophisticated, non-invasive disposable sensor-based temperature management systems, which is anticipated to drive market expansion in this area.